122828-48-2

Basic information

• Product Name: 4-(cyclopropylmethoxy)aniline
• Synonyms: 4-(cyclopropylmethoxy)aniline
• CAS NO: 122828-48-2
• Molecular Formula: C₁₀H₁₃NO
• Molecular Weight: 163.21632
• Mol File: 122828-48-2.mol
• Article Data: 10

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 4-(cyclopropylmethoxy)aniline(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(cyclopropylmethoxy)aniline(122828-48-2)
• EPA Substance Registry System: 4-(cyclopropylmethoxy)aniline(122828-48-2)

Safety Data

• Hazardous Substances Data: 122828-48-2(Hazardous Substances Data)

Upstream product

• 123-30-8 4-amino-phenol 
• 7051-34-5 cyclopropylcarbinyl bromide 
• 98-95-3 nitrobenzene 
• 350-46-9 4-Fluoronitrobenzene 
• 100-02-7 4-nitro-phenol 
• 85002-74-0 1-{(cyclopropyl)methoxy}-4-nitrobenzene 

Downstream Products

• 1236764-60-5 3-[4-(cyclopropylmethoxy)phenyl]-2-thioxo-1,2,3,5-tetrahydro-4H-pyrrolo[3,2-d]pyrimidin-4-one 
• 1236764-91-2 3-[4-(cyclopropylmethoxy)phenyl]-2-thioxo-1,2,3,7-tetrahydro-4H-pyrrolo[2,3-d]pyrimidin-4-one 
• 74773-28-7 5-(4-Cyclopropylmethoxy-benzyl)-thiazolidine-2,4-dione 

Relevant articles and documents

AMINATION AND HYDROXYLATION OF ARYLMETAL COMPOUNDS

In one aspect, the present disclosure provides methods of preparing a primary or secondary amine and hydroxylated aromatic compounds. In some embodiments, the aromatic compound may be unsubstituted, substituted, or contain one or more heteroatoms within the rings of the aromatic compound. The methods described herein may be carried out without the need for transition metal catalysts or harsh reaction conditions.

SUBSTITUTED TRICYCLIC COMPOUNDS WITH ACTIVITY TOWARDS EP1 RECEPTORS

The present invention belongs to the field of EP1 receptor ligands. More specifically it refers to compounds of general formula (I) having great affinity and selectivity for the EP1 receptor. The invention also refers to the process for their preparation, to their use as medicament for the treatment and/or prophylaxis of diseases or disorders mediated by the EP1 receptor as well as to pharmaceutical compositions comprising them.

Fused ring compound and use thereof

The present invention provides a compound represented by the formula: wherein the symbols are as described in the specification, or a salt thereof, which is useful for preventing/treating eicosanoid-associated diseases such as atherosclerosis, diabetes, obesity, atherothrombosis, asthma, fever, pain, cancer, rheumatism, osteoarthritis and atopic dermatitis, and which has an excellent pharmacological action, physicochemical properties, etc.